K Number
K191356
Date Cleared
2022-01-11

(966 days)

Product Code
Regulation Number
890.3800
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The device is intended for medical purposes to provide mobility to persons restricted to a sitting position.

Device Description

The device "i3" is an indoor/outdoor use mobility scooter that is intended to be used by a person who is able to walk but still with "minor mobility problems." The mobility scooter "i3" is composed of metal alloy frame, two front wheels, two rear wheels, two anti-tip wheels, a speed control throttle lever for high/low speed adjustment, a upper control console with a battery indicator, a horn, a key, and a speed control dial, a Li-ion battery with an off-board charger, a motor/electromagnetic brake assembly, an electric motor controller, and a seat/backrest set. The overall dimension of the scooter is L1014W468H981 mm. The total weight of the scooter is 25 kg without battery inside. It can easily be folded and unfolded for transportation in a car boot. The maximum weight capacity of "i3" is 300 lbs. (Approx.136 kg), and its maximum speed is allowed 4 mph (Approx. 6 km/h).

AI/ML Overview

This document describes a 510(k) submission for the "i3 Foldable Mobility Scooter." It's important to understand that a 510(k) submission primarily demonstrates substantial equivalence to a previously cleared predicate device, rather than proving novel safety and efficacy through clinical studies per se. The "acceptance criteria" here are typically compliance with recognized consensus standards and a comparison to the predicate device.

Here's a breakdown of the requested information based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

The acceptance criteria are generally fulfillment of relevant safety and performance standards for mobility scooters. The reported performance is demonstrated by passing these tests.

Acceptance Criteria (Standard)Reported Device Performance (Summary from text)
ISO 7176-13: Determination of coefficient of friction of test surfacesThe device "i3" is designed to fulfill the requirements of this standard. Report stated as found in "004 Appendix B".
ISO 7176-15: Requirements for information disclosure, documentation and labelingThe device "i3" is designed to fulfill the requirements of this standard.
ISO 7176-4: Energy consumption of electric wheelchairs and scooters for determination of theoretical distance rangeThe device "i3" is designed to fulfill the requirements of this standard. Max distance of travel on charged battery approx. 9.13 km.
ISO 7176-5: Determination of overall dimensions, mass and maneuvering spaceThe device "i3" is designed to fulfill the requirements of this standard. Overall dimension: L1014W468H981 mm; Total weight (without battery): 25 kg; Max weight capacity: 300 lbs (136 kg).
ISO 7176-10: Determination of obstacle-climbing ability of electrically powered wheelchairsThe device "i3" is designed to fulfill the requirements of this standard.
ISO 7176-14: Power and control systems for electrically powered wheelchairs and scooters - Requirements and test methodsThe device "i3" is designed to fulfill the requirements of this standard. Braking system is electromagnetic; automatic engagement on lever release. PG S45 controller detects faults and stops the scooter.
ISO 7176-21: Requirements and test methods for electromagnetic compatibility of electrically powered wheelchairs and scooters, and battery chargersThe device "i3" is designed to fulfill the requirements of this standard. Also mentioned: ANSI/RESNA WC 2, Section 21 for EMC test.
ISO 7176-9: Climatic tests for electric wheelchairsThe device "i3" is designed to fulfill the requirements of this standard.
ISO 7176-11: Test dummiesThe device "i3" is designed to fulfill the requirements of this standard.
ISO 7176-16: Resistance to ignition of postural support devicesThe device "i3" is designed to fulfill the requirements of this standard.
ISO 7176-3: Determination of effectiveness of brakesThe device "i3" is designed to fulfill the requirements of this standard. Information on time to brake for noted stopping distance on page 3 of test report.
ISO 7176-1: Determination of static stabilityThe device "i3" is designed to fulfill the requirements of this standard.
ISO 7176-7: Measurement of seating and wheel dimensionsThe device "i3" is designed to fulfill the requirements of this standard.
ISO 7176-8: Requirements and test methods for static, impact and fatigue strengthsThe device "i3" is designed to fulfill the requirements of this standard.
ISO 7176-2: Determination of dynamic stability of electrically powered wheelchairsThe device "i3" is designed to fulfill the requirements of this standard. Max safe speed to prevent tip over: 3 km/hr. Min turning radius to prevent tip over: 1500 mm.
ISO 7176-6: Determination of maximum speed, acceleration and deceleration of electric wheelchairsThe device "i3" is designed to fulfill the requirements of this standard. Max speed allowed: 4 mph (6 km/h).
ISO 7176-30: Wheelchairs --Part 30: Wheelchairs for changing occupant posture --Test methods and requirementsThe device "i3" is designed to fulfill the requirements of this standard.
ANSI/RESNA WC-1:2019 (multiple sections) & WC-2:2019 (multiple sections)The device "i3" is designed to fulfill the requirements of these standards.
IEC 60335-2-29: Safety of household and similar electrical applianceThe device "i3" is designed to fulfill the requirements of this standard.
IEC 62133: Secondary Cells and Batteries – Safety RequirementsThe device "i3" is designed to fulfill the requirements of this standard.
IEC 60601–1–6 and IEC 62366: Medical Electrical Equipment Usability ReportThe device "i3" is designed to fulfill the requirements of these standards (implicitly, as part of safety/effectiveness).
ISO 10993 (various parts) for BiocompatibilityThe device "i3" is designed to fulfill the requirements of these standards. (Specifically listed 10993-1, -5, -10).

2. Sample Sizes Used for the Test Set and Data Provenance

The document does not specify "sample sizes" in the typical sense for clinical trials. The testing described is bench testing and performance testing of the physical device according to industry standards (ISO, ANSI/RESNA, IEC). Therefore:

  • Sample Size for Test Set: Implicitly, one or more units of the "i3 Foldable Mobility Scooter" were tested as per the requirements of each standard. Specific numbers are not provided, but for design verification, often a small number of units are tested to confirm compliance.
  • Data Provenance: The device is manufactured by PUC Perfect Union Co., LTD. in Taiwan. The testing was conducted to international and national standards recognized globally. The data is from prospective bench and performance testing of their own device.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications

This concept is not directly applicable to this type of submission. "Ground truth" established by experts is typically for diagnostic devices where human interpretation is involved. For a mobility scooter, compliance with engineering and safety standards is determined by measurement and observation against predefined criteria, not expert consensus on an interpretation. The "experts" would be the certified test engineers and organizations performing the standardized tests.

4. Adjudication Method for the Test Set

Not applicable. Adjudication methods (like 2+1, 3+1) are used in studies where multiple human readers assess data, and disagreements need resolution (e.g., in radiology image interpretation). The tests for a mobility scooter are objective measurements and performance checks against established thresholds in standards.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size

No, an MRMC comparative effectiveness study was not done. This type of study is for evaluating the impact of an AI system on human reader performance, typically for diagnostic or screening devices. The i3 Foldable Mobility Scooter is a physical mobility aid, not an AI-assisted diagnostic tool.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

No, a standalone algorithm performance study was not done. This device does not feature an AI algorithm that would operate in a "standalone" fashion.

7. The Type of Ground Truth Used

The "ground truth" for this device's performance is defined by the specific requirements and test methods outlined in the cited international and national consensus standards (e.g., ISO 7176 series, ANSI/RESNA WC series, IEC standards). Compliance means the device's measured performance characteristics (e.g., speed, braking distance, stability, battery range) fall within the acceptable parameters defined by these standards.

8. The Sample Size for the Training Set

Not applicable. This device is a physical product, not a machine learning model, so there is no "training set."

9. How the Ground Truth for the Training Set Was Established

Not applicable, as there is no training set.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.

January 11, 2022

PUC Perfect Union Co., LTD. Anita Chen Advisor 8F-4, No.20, Lane 609, Sec. 5, Chungshin Road Sanchung District New Taipei City, 241 Taiwan

Re: K191356

Trade/Device Name: i3 Foldable Mobility Scooter Regulation Number: 21 CFR 890.3800 Regulation Name: Motorized Three-Wheeled Vehicle Regulatory Class: Class II Product Code: INI Dated: December 13, 2021 Received: December 16, 2021

Dear Anita Chen:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

{1}------------------------------------------------

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Heather Dean, PhD Assistant Director, Acute Injury Devices Team DHT5B: Division of Neuromodulation and Physical Medicine Devices OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K191356

Device Name i3 Foldable Mobility Scooter

Indications for Use (Describe)

The device is intended for medical purposes to provide mobility to persons restricted to a sitting position.

Type of Use (Select one or both, as applicable)

| Prescription Use (Part 21 CFR 801 Subpart D)

X Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary

The 510(k) summary of safety and effectiveness information is submitted as part of the Premarket Notification in compliance with requirements of 21 CFR Part 807.92

1. Submitter's Information

Submitter Name: PUC Perfect Union CO., Ltd. The assigned 510(k) Number: K191356 Establishment Registration NO .: 3013603265 Address: 8F-4, No.20, Ln.609, Sec. 5, Chongxin Rd., Sanchong Dist., New Taipei City, Taiwan. Zip Code: 24159 TEL: +886 2 9993690 Contact Person: Anita Chen Cell Phone: +886(0) 939-855-759 E-mail: m9104303@gmail.com

2. Subject Device Information

Trade Namei3 Foldable Mobility Scooter
Common NameMobility Scooter
Classification NameVehicle, Motorized 3-Wheeled
Review PanelPhysical Medicine
Product CodeINI
Regulation Class2
Regulation Number21 CFR 890.3800

3. Predicate Device Information

K150987, Heartway Medical Products CO., LTD.

Trade NameBrio S19 Powered Mobility Scooter
Common NameMobility Scooter
Classification NameVehicle, Motorized 3-Wheeled
Review PanelPhysical Medicine
Product CodeINI
Regulation Class2
Regulation Number21 CFR 890.3800

4. Indication for Use

The device is intended for medical purposes to provide mobility to persons restricted to a sitting position.

{4}------------------------------------------------

5. Device Description

The device "i3" is an indoor/outdoor use mobility scooter that is intended to be used by a person who is able to walk but still with "minor mobility problems." The mobility scooter "i3" is composed of metal alloy frame, two front wheels, two rear wheels, two anti-tip wheels, a speed control throttle lever for high/low speed adjustment, a upper control console with a battery indicator, a horn, a key, and a speed control dial, a Li-ion battery with an off-board charger, a motor/electromagnetic brake assembly, an electric motor controller, and a seat/backrest set. The overall dimension of the scooter is L1014W468H981 mm. The total weight of the scooter is 25 kg without battery inside. It can easily be folded and unfolded for transportation in a car boot. The maximum weight capacity of "i3" is 300 lbs. (Approx.136 kg), and its maximum speed is allowed 4 mph (Approx. 6 km/h).

The speed limits while in slow is 1 mph, and is between 2~3 mph in normal. The highest curb clearance is 43 mm. The maximum safe speed to prevent tip over during operation is 3 km/hr. The minimum turning radius to prevent tip over during operation is 1500 mm.

The information on the time to brake for each noted stopping distance is given on page 3 of the ISO 7176-3 test report as found in 004 Appendix B of this submission. Other performance standards such as ANSI/RESNA WC-2: 2009 (Section 21) & (Section 14) are applicable to the device subject of the submission. The braking system in the i3 foldable mobility scooter is electromagnetic brake. It will engage automatically as soon as the patient releases the speed lever. If the electrical brake fails, the motor will struggle to turn. This situation causes the motor to struggle and draw more current from the batteries. Then, the power indicator will travel faster from right to left. Meanwhile, the PG S45 controller will detect a fault in the scooter's electrical brakes, and then the scooter will stop by itself instantly.

The maximum distance of travel on the fully charged battery is approximately 9.13 km on a single battery while carrying the maximum weight 3001bs. However, the maximum distance of travel does vary with the condition of battery, loading capability as well as road condition. The device can be operated under safer surfaces, such as riding on smooth and uneven surfaces.

There are no accessories for the i3 Foldable Mobility Scooter.

{5}------------------------------------------------

The device has a small USB port underneath the dashboard. It is safe for a patient to charge the patient/user's cell phone using the standard USB Type-A female port with a connecting cable because the maximum amperage and voltage are less than or equal to 0.5A/5V.

A USB charging port:

  • Standard USB Type-A Female port. ●
  • Provide 5V/0.5A, however, voltage may drop more depends on battery capacity.
  • Caution: the USB port is design for cell phone charging only. Do not use the port for another appliance.

The following surfaces are recommended not to operate on: ●

  • Sand land
  • Wet or icy road
  • Manhole cover
  • Additional person riding or hanging onto the scooter
  • Terrain
  • Never take escalator. Only take the elevator to go up and down stairs
  • Steep incline over 8 degrees
  • Connect to a wrong battery charger
  • Do not fold/unfold the product as accordantly
  • Use a cell phone, walkie, laptop, or other radio transmitter while operating the scooter
  • Turning corner at high speed

{6}------------------------------------------------

  • Drive the scooter under the influence of alcohol, drugs, or medication that may affect the physical or cognitive abilities
  • Power off the product when it is moving
  • Hanging bags or other belonging over the steering throttle
  • Carry passengers or items exceed the maximum carrying weight
  • Neglect of the manufacturer's recommendation
  • Exceed the maximum safe gradient

Performance Testing

The device "i3" is designed to fulfill the requirements of the following safety and performance standards.

1.ISO 7176-13 First edition 1989-08-01 Wheelchairs - Part 13: Determination ofcoefficient of friction of test surfaces
2.ISO 7176-15 First edition 1996-11-15 Wheelchairs - Part 15: Requirements forinformation disclosure, documentation and labeling
3.ISO 7176-4 Third edition 2008-10-01 Wheelchairs - Part 4: Energy consumption ofelectric wheelchairs and scooters for determination of theoretical distance range
4.ISO 7176-5 Second edition 2008-06-01 Wheelchairs - Part 5: Determination ofoverall dimensions, mass and maneuvering space
5.ISO 7176-10 Second edition 2008-11-01 Wheelchairs - Part 10: Determination ofobstacle-climbing ability of electrically powered wheelchairs
6.ISO 7176-14 Second edition 2008-02-15 Wheelchairs - Part 14: Power and controlsystems for electrically powered wheelchairs and scooters - Requirements and testmethods

{7}------------------------------------------------

7.ISO 7176-21 Second edition 2009-04-01 Wheelchairs - Part 21: Requirements andtest methods for electromagnetic compatibility of electrically powered wheelchairsand scooters, and battery chargers
8.ISO 7176-9 Third edition 2009-11-15 Wheelchairs - Part 9: Climatic tests forelectric wheelchairs
9.ISO 7176-11 Second edition 2012-12-01 Wheelchairs - Part 11: Test dummies
10ISO 7176-16 Second edition 2012-12-01 Wheelchairs - Part 16: Resistance toignition of postural support devices
11ISO 7176-3 Third edition 2012-12-15 Wheelchairs - Part 3: Determination ofeffectiveness of brakes
12ISO 7176-1 Third edition 2014-10-01 Wheelchairs - Part 1: Determination of staticstability
13ISO 7176-7 First Edition 1998-05-15 Wheelchairs - Part 7: Measurement of seatingand wheel dimensions
14ISO 7176-8 Second editon 2014-12-15 Wheelchairs - Part 8: Requirements and testmethods for static, impact and fatigue strengths
15ISO 7176-2 Third edition 2017-10 Wheelchairs - Part 2: Determination of dynamicstability of electrically powered wheelchairs
16ISO 7176-6 Third edition 2018-06 Wheelchairs - Part 6: Determination of maximumspeed, acceleration and deceleration of electric wheelchairs
17ISO 7176 - 30 First edition 2018-12 Wheelchairs --Part 30: Wheelchairs forchanging occupant posture --Test methods and requirements
18ANSI RESNA WC-1:2019 Section 1 American National Standard for Wheelchairs -Volume 1: Requirements and Test Methods for Wheelchairs (including Scooters)Section 1: Determination of static stability
19ANSI RESNA WC-2:2019 Section 2 American National Standard for Wheelchairs -Volume 2: Additional Requirements for Wheelchairs (including Scooters) withElectrical Systems Section 2: Determination of dynamic stability of electricallypowered wheelchairs
20ANSI RESNA WC-1:2019 Section 3 American National Standard for Wheelchairs -Volume 1: Additional Requirements for Wheelchairs (including Scooters) Section 3:Determination of effectiveness of brakes

{8}------------------------------------------------

21ANSI RESNA WC-2:2019 Section 4 American National Standard for Wheelchairs -Volume 2: Additional Requirements for Wheelchairs (including Scooters) withElectrical Systems Section 4: Energy consumption of electrically poweredwheelchairs and scooters for determination of theoretical distance range
22ANSI RESNA WC-1:2019 Section 5 American National Standard for Wheelchairs -Volume 1: Requirements and Test Methods for Wheelchairs (including Scooters)Section 5: Determination of dimensions, mass and maneuvering space
23ANSI RESNA WC-2:2019 Section 6 American National Standard for Wheelchairs -Volume 2: Additional Requirements for Wheelchairs (including Scooters) withElectrical Systems Section 6: Determination of maximum speed of electricallypowered wheelchairs.
24ANSI RESNA WC-1:2019 Section 7 American National Standard for Wheelchairs -Volume 1: Requirements and Test Methods for Wheelchairs (including Scooters)Section 7: Method of measurement of seating and wheel dimensions
25ANSI RESNA WC-1:2019 Section 8 American National Standard for Wheelchairs -Volume 1: Requirements and Test Methods for Wheelchairs (including Scooters)Section 8: Requirements and test methods for static, Iipact and fatigue strengths
26ANSI RESNA WC-2:2019 Section 9 American National Standard for Wheelchairs -Volume 2: Additional Requirements for Wheelchairs (including Scooters) withElectrical Systems Section 9: Climatic tests for Electrically powered wheelchairs
27ANSI RESNA WC-2:2019 Section 10 American National Standard for Wheelchairs- Volume 2: Additional Requirements for Wheelchairs (including Scooters) withElectrical Systems Section 10: Determination of obstacle-climbing ability ofelectrically powered wheelchairs
28ANSI RESNA WC-1:2019 Section 11 American National Standard for Wheelchairs -Volume 1: Requirements and Test Methods for Wheelchairs (including Scooters)Section 11: Test mannequins
29ANSI RESNA WC-1:2019 Section 13 American National Standard for Wheelchairs- Volume 1: Requirements and Test Methods for Wheelchairs (including Scooters)Section 13: Determination of Coefficient of Friction of Test Surfaces
30ANSI RESNA WC-2:2019 Section 14 American National Standard for Wheelchairs- Volume 2: Additional Requirements for Wheelchairs (including Scooters) with

{9}------------------------------------------------

Electrical Systems Section 14: Power and Control Systems for Electrically PoweredWheelchairs Requirements and Test Methods
31ANSI RESNA WC-1:2019 Section 15 American National Standard for Wheelchairs -Volume 1: Requirements and Test Methods for Wheelchairs (including Scooters)Section 15: Requirements for Information Disclosure, Documentation and Labeling
32ANSI RESNA WC-1:2019 Section 16 American National Standard for Wheelchairs- Volume 1: Requirements and Test Methods for Wheelchairs (including Scooters)Section 16: Resistance to Ignition of Upholstered Parts - Requirements and TestMethods
33ANSI RESNA WC-1:2019 Section 22 American National Standard for Wheelchairs -Volume 1: Requirements and Test Methods for Wheels chairs (including Scooters)Section 22: Set-up Procedures
34ANSI RESNA WC-2:2019 Section 21 American National Standard for Wheelchairs -Volume 2, Additional Requirements for Wheelchairs (including Scooters) withElectrical Systems Section 21: Requirements and test methods for electromagneticcompatibility of electrically powered wheelchairs and motorized scooters
35IEC 60335-2-29: Safety of household and similar electrical appliance
36IEC 62133: Secondary Cells and Batteries Containing Alkaline or other Non-AcidElectrolytes – Safety Requirements for Portable Sealed Secondary Cells and forBatteries Made From Them for Use in Portable Applications
37IEC 60601–1–6 and IEC 62366: Medical Electrical Equipment Usability Report
38ANSI/RESNA WC-2: 2009 (Section 21) Electrically powered wheelchairs, scooters,and their chargers – requirements and test methods
39ANSI/RESNA WC-2: 2009 (Section 14) Power and control system for electricallypowered wheelchairs and scooters – requirements and test methods
40ISO 10993 –10 Skin Sensitization (Maximization)
41ISO 10993 –5 Vitro Cytotoxicity
42ISO 10993-10 Irritation and Skin Sensitization

6. Comparison

{10}------------------------------------------------

ItemSubject DevicePredicate DeviceSubstantial
(K150987)Equivalent
Results
ManufacturerPUCHeartway
Model No.i3BRIO S19
Indication for useThe device is intendedThe device is intendedSame
for medical purposes tofor medical purposes to
provide mobility toprovide mobility to
persons restricted to apersons restricted to a
sitting position.sitting position.
ElectronicsPenny & GilesPenny & GilesSame
controllerS-DriveS-Drive
ArmrestNo armrestNo armrestSame
Height adjustableYesYesSame
tiller
Back upholsteryFabricFabricSame
Wheel LockPush-to-lockPush-to-lockSame
FrameFixed/Aluminum alloyFixed/Aluminum alloySame
BrakeElectromagneticElectromagneticSame
Anti-tipperYesYesSame
Driving systemRear wheel driveRear wheel driveSame
Rear wheel8"X2" solidX28"X2" solidX2Same
Manual foldingYesYesSame
only
OperatingIndoor/outdoorIndoor/outdoorSame
Environments
Overall dimensionL1014mm / 39.9"930 mm / 36.6"Larger
Overall LengthW468mm /18.4"485 mm / 19.0"Dimension
Overall WidthH981 mm /38.6"945 mm / 37.2"
Overall Height
Seat dimensionW400mm /15.7"395 mm / 15.5"Same
Seat WidthH355 mm /13.98"350 mm / 13.75"
Seat Height
Weightw/batteries 26.99kgsw/batteries 31.3kgs /69Minor
/59.5 lbslbsdifferent

{11}------------------------------------------------

w/o batteries 25.24kgs/ 55.6 lbsw/o batteries 24.0kgs /53 lbs
Battery weight1.72 kg for one3 kgMinordifferent
USB charging portYesNodifferent
Ground clearance43 mm / 1.7"60 mm / 2.3"Minordifferent,more safety.
Front caster7"x1.75" solid X27"x1.6" solid X2Minordifferent
Turning Radius1500mm/59"820mm/32.2"Minordifferent forstabledesign.
InclineSafe ClimbingAngle8 Degree6 DegreeMinordifferent forLarger safeclimbingAngle
Range per fullcharging9.13 km / 5.67miles(for one battery18 km / 11.25 milesMinordifferent
Maximum speed6 km/hr (3.7 mile/h)8.0 km/hr (5mile/h)Minordifferent
Motor24V, 270W3A 24V, 270W@1same
Kerb climbing50 mm/2"45 mm/1.7"Minordifferent
Battery chargerVoltage outputModelExternal (off-board)chargerDC29.4V (ULE491233 CE)IN2902000External (off-board)charger24VDC (UL E201162)4C24050AMinordifferent
MaximumCapability137 kg / 300lbs100 kg / 220lbsdifferent
BatteryTwo Li – Battery25.2V/11.6AHTwo12Ah /12VDCMinordifferent

{12}------------------------------------------------

BiocompatibilityISO10993-1:2018ISO 10993-1:2009same
ISO 10993-5:2009ISO 10993-5:2009
ISO 10993-10:2010ISO 10993-10:2010

Despite of the above differences, the two devices all completed the performance tests in accordance with ISO 7176 series standards and the ANSI / RESNA WC 2, Section 21 for the EMC test. There are no safety and effectiveness aspects concerned. Thus, the two devices are substantially equivalent.

7. Conclusion

Based on the similarities and differences discussions above, the subject device is as safe and effective as the predicate device because the subject device is a lot like the predicate device which has already been reviewed and cleared by FDA. Besides, the comparison of different characteristics with the predicate device demonstrates that the subject device is as safe and effective because the results of these tests do not affect the safety and effectiveness after verified by related performance tests. Since both devices were tested using the same FDA Recognized Consensus Standards, PUC believes that the data generated from the Heartway supports the findings of substantial equivalence. Thus, the subject device is substantially equivalent to the predicate device (K150987).

The conclusions drawn from the non-clinical tests demonstrate that the device is as safe, as effective, and performs as well as the legally marketed device identified in the submission. Thus, the subject device is substantially equivalent to the predicate device.

§ 890.3800 Motorized three-wheeled vehicle.

(a)
Identification. A motorized three-wheeled vehicle is a gasoline-fueled or battery-powered device intended for medical purposes that is used for outside transportation by disabled persons.(b)
Classification. Class II (performance standards).